The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways-Reference-Cited by-同舟云学术

The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Published:2020-09 Issue: Volume:259 Page:112852
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Liao Zhi-Hong,Zhu Hong-Qing,Chen Yan-Yan,Chen Run-Li,Fu Li-Xiang,Li Li,Zhou Huan,Zhou Jin-Ling,Liang Gang

Funder

National Natural Science Foundation of China

Guangxi Natural Science Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference42 articles.

1. Mortality and Prevalence of All Cancers (excluding non-melanoma skin cancer) in 2012;JNCI J. Natl. Cancer Inst.,2017

2. Oncogenic PI3K deregulates transcription and translation;Bader;Nat. Rev. Canc.,2005

3. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells;Braicu;J. Nanosci. Nanotechnol.,2013

4. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

5. Molecular mechanisms and clinical applications of angiogenesis;Carmeliet;Nature,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier-Free Hybrid Nanoparticles for Enhanced Photodynamic Therapy in Oral Carcinoma via Reversal of Hypoxia and Oxidative Resistance;Pharmaceutics;2024-08-27

2. Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate;Nutrients;2024-06-28

3. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

4. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets;Molecules;2024-03-20

5. Genetically predicted Vascular endothelial growth factor A mediates the association between CD3+ CD8+ TD T cell and Colorectal cancer: A Mendelian randomization analysis;2024-02-20